What is Pertuzumab?

Category: Prescription Drugs

Most popular types: Perjeta

false

See also: Docetaxel-carboplatin-trastuzumab-pertuzumab Docetaxel-trastuzumab-pertuzumab (DHP) Doxorubicin-cyclophosphamide-docetaxel-trastuzumab-pertuzumab Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab-pertuzumab (AC-THP) Paclitaxel-trastuzumab-pertuzumab (THP)

Pertuzumab is a HER2/neu receptor blocker that is used in combination with other chemotherapy agents for the treatment of patients with HER2-positive, metastatic breast cancer.

Why patients stopped taking Pertuzumab

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 1
See 1 patient who's stopped taking Pertuzumab

Duration

Stopped taking Pertuzumab

Duration Patients Percentage
1 - 6 months 1

What people switch to and from

Patients stopped taking Pertuzumab and switched to:

Treatment Patients Percentage
Ado-trastuzumab emtansine (Kadcyla) 1
Last updated:
There are no evaluations for Pertuzumab.